IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. [JAMA Oncol. 2018] Comment on: Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher HI, Morris MJ, Larson SM. JAMA Oncol. 2018 Feb 1;4(2):217-224. doi: 10.1001/jamaoncol.2017.3588.

Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer / B. Rocco, A. Eissa, G. Bianchi. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 73:4(2018), pp. 639-640. [10.1016/j.eururo.2017.12.004]

Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer

B. Rocco
;
2018

Abstract

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. [JAMA Oncol. 2018] Comment on: Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher HI, Morris MJ, Larson SM. JAMA Oncol. 2018 Feb 1;4(2):217-224. doi: 10.1001/jamaoncol.2017.3588.
Sì
English
Biomarkers; Humans; Male; Multimodal Imaging; Prognosis; Prostatic Neoplasms; Prostatic Neoplasms; Castration-Resistant; Receptors; Androgen; Urology
Settore MED/24 - Urologia
Nota o Commento
Esperti anonimi
Pubblicazione scientifica
2018
EUROPEAN UROLOGY
Elsevier
73
4
639
640
2
Pubblicato
Periodico con rilevanza internazionale
MIUR-ALTRI-IRIS
WOS:000427486600039
2-s2.0-85038937611
29274864
Aderisco
info:eu-repo/semantics/article
Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer / B. Rocco, A. Eissa, G. Bianchi. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 73:4(2018), pp. 639-640. [10.1016/j.eururo.2017.12.004]
reserved
Prodotti della ricerca::01 - Articolo su periodico
3
262
Article (author)
si
B. Rocco, A. Eissa, G. Bianchi
01 - Articolo su periodico
File in questo prodotto:
File Dimensione Formato  
senza_titolo.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 149.9 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
149.9 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/876537
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
  • OpenAlex ND
social impact